Patient-derived xenograft models capture genomic heterogeneity in endometrial cancer

BACKGROUND: Endometrial cancer (EC) is a major gynecological cancer with increasing incidence. It comprises four molecular subtypes with differing etiology, prognoses, and responses to chemotherapy. In the future, clinical trials testing new single agents or combination therapies will be targeted to...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonazzi, Vanessa F., Kondrashova, Olga, Smith, Deborah, Nones, Katia, Sengal, Asmerom T., Ju, Robert, Packer, Leisl M., Koufariotis, Lambros T., Kazakoff, Stephen H., Davidson, Aimee L., Ramarao-Milne, Priya, Lakis, Vanessa, Newell, Felicity, Rogers, Rebecca, Davies, Claire, Nicklin, James, Garrett, Andrea, Chetty, Naven, Perrin, Lewis, Pearson, John V., Patch, Ann-Marie, Waddell, Nicola, Pollock, Pamela M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751371/
https://www.ncbi.nlm.nih.gov/pubmed/35012638
http://dx.doi.org/10.1186/s13073-021-00990-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751371/
https://www.ncbi.nlm.nih.gov/pubmed/35012638
http://dx.doi.org/10.1186/s13073-021-00990-z

Ejemplares similares